United States · Series A startup

Who invested in Tactiva Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 27 Oct 2026

$35Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $35MDec 2018
Investors
2
See who backed them

The rounds

  1. Dec 2018
    Series A$35M

    Reported by FinSMEs

Everyone who backed them

EFung CapitalVC firm1round
Panacea Healthcare Partners/ Vino record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Tactiva Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Virtus Inspire VenturesVC firmPer its own site

Quick answers about Tactiva Therapeutics

Who invested in Tactiva Therapeutics?

Tactiva Therapeutics's investors include EFung Capital and Panacea Healthcare Partners/ Vi.

How much has Tactiva Therapeutics raised?

Tactiva Therapeutics has raised $35M across 1 round since 2018.

When did Tactiva Therapeutics last raise?

Tactiva Therapeutics's most recent round was a Series A of $35M in Dec 2018.

What was Tactiva Therapeutics's biggest round?

Its most recent round, $35M in Dec 2018, is also its largest on record.

Who backed Tactiva Therapeutics first?

Tactiva Therapeutics's first round on record, in Dec 2018, was backed by EFung Capital and Panacea Healthcare Partners/ Vi.

What stage is Tactiva Therapeutics at?

Tactiva Therapeutics's latest named round is a Series A, in Dec 2018.

Where is Tactiva Therapeutics based?

Tactiva Therapeutics is based in the United States.

Companies like Tactiva Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.